Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
出版年份 2016 全文链接
标题
Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-05
DOI
10.1038/srep20502
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling
- (2014) Hongying Duan et al. CANCER LETTERS
- Mycoplasma Hyorhinis Infection Promotes NF- B-Dependent Migration of Gastric Cancer Cells
- (2014) H. Duan et al. CANCER RESEARCH
- VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance
- (2014) Hee Jun Cho et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- HER2-positive gastric cancer
- (2013) Narikazu Boku Gastric Cancer
- Assessing HER2 amplification by IHC, FISH, and real-time polymerase chain reaction analysis (real-time PCR) following LCM in formalin-fixed paraffin embedded tissue from 40 women with ovarian cancer
- (2012) Thore Hillig et al. APMIS
- Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer
- (2012) Na Ri Shin et al. BMC CANCER
- Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
- (2012) Christina Scheel et al. SEMINARS IN CANCER BIOLOGY
- RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression
- (2011) Hee Jun Cho et al. CANCER LETTERS
- A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
- (2011) Hark Kyun Kim et al. PLoS One
- New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives
- (2010) Dexin Zhang et al. Future Oncology
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
- (2009) Jose Miguel López-Novoa et al. EMBO Molecular Medicine
- Epithelial–mesenchymal transition in tumor metastasis: a method to the madness
- (2009) Venkateshwar G Keshamouni et al. Future Oncology
- Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance
- (2009) Guan Zhen Yu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer
- (2009) Wen-Qing Hu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started